Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion type Assertion NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_head.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion wasGeneratedBy ECO_0000203 NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion wasDerivedFrom befree-2016 NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion SIO_000772 15791568 NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion evidence source_evidence_literature NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion description "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.